Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Do lipitor's side effects differ between young and old adults?
Lacosamide maximum dose?
Lipitor patent expiration?
Glucosamine blood thinning?
Cosentyx breastfeeding?

Where was keytruda developed?

See the DrugPatentWatch profile for keytruda

Keytruda (pembrolizumab) was developed by the U.S. biotechnology company Merck (known as Merck Sharp & Dohme, a division of Merck & Co.). It is an antibody drug that came from Merck’s internal research and development program for immuno-oncology therapies.



Other Questions About Keytruda :

Can you recall the initial cancer for keytruda's launch? Are there cost saving options for keytruda versus alternative immunotherapies? What is the co pay for keytruda? Keytruda's initial fda approved use which cancer? Keytruda problems? How can i obtain keytruda authorization? What is keytruda's fda approval date for its wide application?